Comparison results
| Results: Differences General | ✘B48.8 | ✘B45 | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| fever cough | 78% | — | ||||
| cryptococcosis of the lungs | — | 97% | ||||
| cough when inhaling | 78% | — | ||||
| nystagmus | — | 94% | ||||
| cough | 70% | — | ||||
| lower respiratory tract infections | — | 63% | ||||
| feeling of heat | 63% | — | ||||
| ARVI | — | 57% | ||||
| coccidiomycosis | 62% | — | ||||
| slow onset of the disease | — | 46% | ||||
| changeable stool | 61% | — | ||||
| meningoencephalitis | — | 44% | ||||
| fungus | 85% | 29% | ||||
| meningitis | — | 42% | ||||
| fungal mycosis | 53% | — | ||||
| hemiplegia | — | 41% | ||||
| scalp soreness | 51% | — | ||||
| colds with temperatures | — | 41% | ||||
| breath no itching | 50% | — | ||||
| colds with high fever | — | 41% | ||||
| fever is active | 48% | — | ||||
| weakening of immunity | — | 40% | ||||
| corneal ulcer | 48% | — | ||||
| headache frontal | — | 40% | ||||
| swelling of joints | 43% | — | ||||
| subfebrility | — | 40% | ||||
| headache with fever | 42% | — | ||||
| unbearable headache | — | 40% | ||||
| headache at temperature | 41% | — | ||||
| paralysis | — | 39% | ||||
| sputum with blood | 41% | — | ||||
| systemic mycosis | — | 38% | ||||
| feeling of heat in the head | 40% | — | ||||
| paralysis of the lower extremities | — | 36% | ||||
| keratitis | 40% | — | ||||
| meningeal symptoms | — | 36% | ||||
| encephalitis | 39% | — | ||||
| sputum is scanty | — | 36% | ||||
| feeling the heat in the skin | 38% | — | ||||
| lymphogranulomatosis | — | 36% | ||||
| ulcers on the skin | 38% | — | ||||
| meningeal syndrome | — | 33% | ||||
| lung pain | 37% | — | ||||
| heaviness in the body | — | 33% | ||||
| red rash | 37% | — | ||||
| onset of illness | — | 32% | ||||
| general swelling does | 36% | — | ||||
| primary immunodeficiency | — | 32% | ||||
| tuberculosis | 36% | — | ||||
| malignant lymphoma | — | 31% | ||||
| joint pain | 36% | — | ||||
| headache attacks | — | 31% | ||||
| skin spots | 36% | — | ||||
| lowered | — | 30% | ||||
| violation of the stool | 35% | — | ||||
| lymphoma | — | 30% | ||||
| papules | 34% | — | ||||
| coma | — | 30% | ||||
| joint diseases | 33% | — | ||||
| unbearable pain | — | 29% | ||||
| soreness of the skin | 33% | — | ||||
| painful appearance | — | 28% | ||||
| swelling | 30% | — | ||||
| delirium | — | 27% | ||||
| blood diseases | 29% | — | ||||
| disorders of consciousness | — | 27% | ||||
| high temperature | 62% | 33% | ||||
| respiratory insufficiency | — | 27% | ||||
| immunodeficiency | 48% | 36% | ||||
| gradual deterioration of the condition | — | 26% | ||||
| sputum | 38% | 29% | ||||
| confusion of consciousness | — | 26% | ||||
| headaches | 32% | 24% | ||||
| pneumonia | — | 26% | ||||
| serious condition | 35% | 27% | ||||
| madness | — | 26% | ||||
| patient's condition | 28% | 21% | ||||
| exhaustion after illness | — | 26% | ||||
| impaired lung function | 53% | 49% | ||||
| impaired venous function | — | 24% | ||||
| dry | — | 24% | ||||
| attacks of pain | — | 24% | ||||
| exhaustion | — | 24% | ||||
| damage to the nervous system | 31% | 49% | ||||
| cryptococcosis | 86% | 98% | ||||
| skin problems | 29% | 38% | ||||
| leukoencephalitis | 36% | 38% | ||||
| blastomycosis | 38% | 40% | ||||
| hiv | 36% | 38% | ||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
